Actieve functies van Marc Dechamps
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
| OSE IMMUNOTHERAPEUTICS | Directeur/Bestuurslid | 19-06-2024 | - |
| Independent Dir/Board Member | 19-06-2024 | - |
Loopbaan van Marc Dechamps
Eerdere bekende functies van Marc Dechamps
| Bedrijven | Functie | Begin | Einde |
|---|---|---|---|
Delphi Genetics SA
 Delphi Genetics SA BiotechnologyHealth Technology Delphi Genetics SA develops products and technologies for gene cloning and protein expression in bacteria. It offers deoxyribonucleic acid (DNA), antibody development, molecular biology, protein purification, vector adaption, and DNA immunization services. The company was founded by Philippe Gabant, Michel Milinkovitch, and Cedric Szpirer in 2001 and is headquartered in Charleroi, Belgium. | Algemeen Directeur | - | 01-07-2017 |
eTheRNA immunotherapies NV
 eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Directeur/Bestuurslid | - | - |
| Corporate Officer/Principal | - | - |
Statistieken
Internationaal
| België | 3 |
| Frankrijk | 2 |
Operationeel
| Director/Board Member | 2 |
| Chief Executive Officer | 1 |
| Corporate Officer/Principal | 1 |
Sectoraal
| Health Technology | 4 |
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Verwante bedrijven
| Beursgenoteerde bedrijven | 1 |
|---|---|
| OSE IMMUNOTHERAPEUTICS | Health Technology |
| Bedrijven in privébezit | 2 |
|---|---|
Delphi Genetics SA
Delphi Genetics SA BiotechnologyHealth Technology Delphi Genetics SA develops products and technologies for gene cloning and protein expression in bacteria. It offers deoxyribonucleic acid (DNA), antibody development, molecular biology, protein purification, vector adaption, and DNA immunization services. The company was founded by Philippe Gabant, Michel Milinkovitch, and Cedric Szpirer in 2001 and is headquartered in Charleroi, Belgium. | Health Technology |
eTheRNA immunotherapies NV
eTheRNA immunotherapies NV BiotechnologyHealth Technology eTheRNA immunotherapies NV develops novel immunotherapies to overcome cancers and infectious diseases. The company was founded by Carlo Heirman, Kris Thielemans and Sonja van Meirvenne in January 21, 2013 and is headquartered in Niel, Belgium. | Health Technology |
- Beurs
- Insiders
- Marc Dechamps
- Ervaring
